Evofem Biosciences, Inc. (EVFM)
OTCMKTS
· Delayed Price · Currency is USD
0.0093
0.00 (0.43%)
Aug 14, 2025, 12:21 PM EDT
Evofem Biosciences Employees
Evofem Biosciences had 32 employees as of December 31, 2024. The number of employees decreased by 6 or -15.79% compared to the previous year.
Employees
32
Change (1Y)
-6
Growth (1Y)
-15.79%
Revenue / Employee
$518,906
Profits / Employee
-$98,625
Market Cap
1.10M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Tian'an Technology Group | 8 |
Elite Pharmaceuticals | 68 |
Glass House Brands | 374 |
American Oncology Network | 1,914 |
Northwest Biotherapeutics | 25 |
CytoDyn | 13 |
Silence Therapeutics | 116 |
Evofem Biosciences News
- 1 hour ago - Evofem Biosciences GAAP EPS of -$0.02, revenue of $4.8M - Seeking Alpha
- 3 hours ago - Evofem Reports Positive Financial Results for Second Quarter of 2025, Provides Business Update - PRNewsWire
- 9 days ago - Evofem CEO Saundra Pelletier Honored with Trailblazing Female Founders Award at STIMULATE Conference - PRNewsWire
- 7 weeks ago - Evofem's PHEXXI Submitted for Marketing Approval in United Arab Emirates by Pharma 1 Drug Store - PRNewsWire
- 2 months ago - Evofem Biosciences' CEO Saundra Pelletier Joins Aditxt Board of Directors - Business Wire
- 3 months ago - Evofem Signs SOLOSEC License Agreement for Middle East with Pharma 1 - PRNewsWire
- 3 months ago - Evofem Biosciences GAAP EPS of $0.00, revenue of $0.85M - Seeking Alpha
- 3 months ago - Evofem Reports First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire